A detailed history of Goelzer Investment Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Goelzer Investment Management, Inc. holds 1,340 shares of AMGN stock, worth $375,213. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,340
Previous 1,365 1.83%
Holding current value
$375,213
Previous $426,000 1.17%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$309.38 - $337.38 $7,734 - $8,434
-25 Reduced 1.83%
1,340 $431,000
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $11,298 - $13,730
43 Added 3.25%
1,365 $426,000
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $44,363 - $53,552
165 Added 14.26%
1,322 $375,000
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $295,844 - $333,748
1,157 New
1,157 $333,000
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $186,952 - $222,626
-864 Closed
0 $0
Q3 2020

Oct 27, 2020

SELL
$234.65 - $260.95 $7,743 - $8,611
-33 Reduced 3.68%
864 $220,000
Q2 2020

Aug 12, 2020

BUY
$197.81 - $242.74 $177,435 - $217,737
897 New
897 $212,000
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $229,440 - $304,300
-1,259 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$189.21 - $243.2 $39,734 - $51,072
-210 Reduced 14.3%
1,259 $304,000
Q3 2019

Nov 06, 2019

SELL
$174.11 - $208.62 $67,728 - $81,153
-389 Reduced 20.94%
1,469 $284,000
Q2 2019

Jul 29, 2019

SELL
$166.7 - $195.41 $6,834 - $8,011
-41 Reduced 2.16%
1,858 $342,000
Q1 2019

May 03, 2019

BUY
$180.87 - $203.88 $72,348 - $81,552
400 Added 26.68%
1,899 $361,000
Q1 2018

May 07, 2018

SELL
$169.43 - $198.0 $16,943 - $19,800
-100 Reduced 6.25%
1,499 $256,000
Q3 2017

Oct 31, 2017

BUY
$167.29 - $191.0 $267,496 - $305,409
1,599
1,599 $298,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Goelzer Investment Management, Inc. Portfolio

Follow Goelzer Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goelzer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Goelzer Investment Management, Inc. with notifications on news.